A detailed history of Black Rock Inc. transactions in Minerva Neurosciences, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 72,669 shares of NERV stock, worth $162,778. This represents 0.0% of its overall portfolio holdings.

Number of Shares
72,669
Previous 72,669 -0.0%
Holding current value
$162,778
Previous $187,000 23.53%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$6.9 - $13.05 $42,517 - $80,414
-6,162 Reduced 7.82%
72,669 $501,000
Q4 2022

Feb 13, 2023

BUY
$1.43 - $13.43 $1,065 - $10,005
745 Added 0.95%
78,831 $125,000
Q3 2022

Nov 14, 2022

BUY
$2.53 - $13.17 $69,858 - $363,650
27,612 Added 54.71%
78,086 $721,000
Q2 2022

Aug 12, 2022

BUY
$2.7 - $7.68 $136,279 - $387,640
50,474 New
50,474 $166,000

Others Institutions Holding NERV

About Minerva Neurosciences, Inc.


  • Ticker NERV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,340,190
  • Market Cap $12M
  • Description
  • Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein ...
More about NERV
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.